Related Experiment Video
Updated: May 31, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Basal insulin: beyond glycemia
1Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University School of Medicine, Nashville, TN 37232-0475, USA. Kevin.niswender@vanderbilt.edu
Postgraduate Medicine
|June 18, 2011
Summary
Insulin resistance impacts numerous organs beyond glucose metabolism, leading to serious health issues. Understanding insulin
Area of Science:
- Endocrinology
- Metabolic Science
- Physiology
Background:
- Insulin is a pleiotropic hormone affecting carbohydrate, lipid, and protein metabolism.
- Insulin resistance, a key factor in diabetes, impairs cellular signaling.
- The widespread effects of insulin resistance contribute to conditions like metabolic syndrome and cardiovascular disease.
Purpose of the Study:
- To provide an integrated view of insulin action across various tissues.
- To discuss the pathophysiology of diabetes and the role of insulin resistance.
- To explore the clinical efficacy and therapeutic potential of insulin.
Main Methods:
- Review of existing literature on insulin's physiological and pathophysiological effects.
- Discussion of cellular and molecular mechanisms of insulin signaling.
- Analysis of clinical consequences of insulin resistance beyond hyperglycemia.
Main Results:
- Insulin resistance has profound effects on multiple organ systems, not just glucose metabolism.
- Impaired insulin signaling contributes to hyperglycemia, hypertension, dyslipidemia, and cardiovascular/renal disease.
- A comprehensive understanding of insulin's action is crucial for improved diabetes and metabolic syndrome management.
Conclusions:
- An integrated perspective on insulin action can reveal new therapeutic strategies.
- Enhanced understanding of insulin's role beyond glycemia is vital for clinicians.
- Addressing insulin resistance comprehensively can improve patient outcomes in diabetes and metabolic syndrome.
Related Concept Videos
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

